ProKidney Operating Income

The latest operating income for PROK is $-120M as of March 2026. That compares with $-140M in the prior-year period — up 9.1% year over year. Investors often review this figure alongside ProKidney's historical trend and sector peers before judging valuation or financial health.

Over the past year, PROK's operating income moved from $-140M to $-120M — a 9.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in ProKidney's operating scale or balance-sheet position.

A operating income figure of $-120M for PROK is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PROK's operating income ($-120M), review year-over-year change from $-140M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.